Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CSTL | ADPT |
|---|---|---|
| Price | $33.00 | $26.28 |
| Change today | ▼ 1.08% | ▼ 2.30% |
| Market cap | $1.01B | $4.19B |
| Return, 3 months | +34.4% | +20.6% |
| Return, year to date | -15.2% | +61.8% |
| Return, 1 year | +39.9% | +69.0% |
| P/E (TTM) | -51.6 | -65.7 |
| P/B | 2.1 | 29.4 |
| P/E percentile vs own 5y | 27th | 2nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +20.1% | +21.5% |
| Net profit growth (YoY) | -145.5% | -56.1% |
| Gross margin | 77.3% | 75.6% |
| Operating margin | -9.0% | -12.2% |
| Net margin | -5.4% | -20.7% |
| Return on equity | -4.2% | -39.6% |
| Analyst target vs. price | +37.6% | +16.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 44 | 46 |
| 30-day volatility | 43.4% | 55.4% |
| Max drawdown, 1 year | -57.8% | -39.3% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
